文献速递关节外科

静脉序贯口服氨甲环酸对全膝关节置换术后血红蛋白下降的影响:随机对照试验

Effect of Sequential Intravenous and Oral Tranexamic Acid on Hemoglobin Drop After Total Knee Arthroplasty: A Randomized Controlled Trial.
PubMed 文献 · J Bone Joint Surg Am · 2022-01-01

这项前瞻性随机对照试验纳入141例全膝关节置换术患者,比较单用静脉氨甲环酸与静脉后序贯口服2天或5天氨甲环酸的差异。结果显示三组最大血红蛋白下降、估计失血量及输血率均无差异,且序贯口服未增加深静脉血栓或肺栓塞发生率,但亦未降低血红蛋白下降,故不推荐序贯使用。

要点

  • 静脉后序贯口服氨甲环酸2天或5天均未降低全膝关节置换术后血红蛋白下降。
  • 三组估计失血量与输血率无差异,每组各1例需输血。
  • 序贯口服氨甲环酸未增加症状性深静脉血栓或肺栓塞发生率。

核心结论

  • 静脉后序贯口服氨甲环酸虽未增加并发症,但未降低血红蛋白下降,不推荐序贯使用。

研究设计与样本

  • 前瞻性随机对照试验,纳入141例全膝关节置换术患者,比较单用静脉氨甲环酸(48例)、序贯口服2天(46例)或5天(47例)的差异。

主要发现

  • 三组最大血红蛋白下降均值分别为静脉组3.5 g/dL、2天组3.2 g/dL、5天组3.4 g/dL,无差异。
  • 三组估计失血量均值分别为静脉组999.9 mL、2天组886.4 mL、5天组972.5 mL,无差异。
  • 每组各1例需输血,输血率无差异。
  • 影像学深静脉血栓及症状性深静脉血栓发生率无差异,症状性深静脉血栓静脉组3例、5天组2例。
  • 静脉组1例发生症状性肺栓塞。

关键数值与推荐

  • 静脉氨甲环酸于松止血带前10分钟及首次给药后3小时各给一次。
  • 术后第6天行CT检查评估影像学深静脉血栓。

临床怎么用

  • 全膝关节置换术后不必常规序贯口服氨甲环酸以进一步减少失血。
  • 若考虑延长氨甲环酸使用,需权衡其未证实的获益与潜在风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tranexamic acid (TXA) is typically discontinued on the day of total knee arthroplasty (TKA). However, bleeding may persist for several days. We sought to determine whether sequential administration of intravenous (IV) and oral TXA could reduce hemoglobin (Hb) drop more than IV TXA alone. We also wanted to determine whether the use of additional oral TXA increased the rate of complications of deep vein thrombosis (DVT) or symptomatic pulmonary embolism (PE). METHODS: This prospective, randomized controlled trial included 141 patients. We compared the Hb drop, estimated blood loss (EBL), and transfusion rate of patients receiving IV TXA alone (group IV, n = 48) to those of patients who received IV TXA followed by oral TXA for 2 days (group 2D, n = 46) or 5 days (group 5D, n = 47). IV TXA was administered 10 minutes prior to the tourniquet release and 3 hours after the first IV TXA administration. Computed tomography (CT) was performed on postoperative day 6 to identify radiographic evidence of DVT. We also assessed the prevalence of symptomatic DVT and PE. RESULTS: There were no differences in maximal Hb drop, Hb drops measured at each time point, EBL, or transfusion rate among the 3 groups. The mean maximal Hb drop was 3.5 g/dL in group IV, 3.2 g/dL in group 2D, and 3.4 g/dL in group 5D. The mean EBL was 999.9 mL in group IV, 886.4 mL in group 2D, and 972.5 mL in group 5D. One patient in each group required a transfusion. There were no differences in the prevalence of radiographic evidence of DVT or symptomatic DVT. Symptomatic DVT occurred in 3 patients in group IV and 2 patients in group 5D. One patient in group IV developed a symptomatic PE. CONCLUSIONS: Although there was no increase in the complication rate, the sequential administration of oral TXA for up to 5 days after IV TXA did not decrease Hb drop. Therefore, our findings suggest that sequential use of oral and IV TXA is not recommended. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Chang MJ, Shin JY, Yoon C, et al. Effect of Sequential Intravenous and Oral Tranexamic Acid on Hemoglobin Drop After Total Knee Arthroplasty: A Randomized Controlled Trial. J Bone Joint Surg Am. 2022. PMID: 34705756. doi:10.2106/JBJS.20.02174

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。